With the $12 million (€11 million) financing, Bone Therapeutics will be able to continue its activities until the first quarter of 2021. Once markets return to...
In September 2019, the first commercial exosome therapeutics conference was held in Boston, an event attended by 15 companies. In the last few years, several universities...